华人健康
(301408)
| 流通市值：31.85亿 | | | 总市值：55.64亿 |
| 流通股本：2.29亿 | | | 总股本：4.00亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,314,724,831.34 | 2,824,690,091.29 | 1,420,983,890.57 | 5,486,683,545.91 |
| 营业收入 | 4,314,724,831.34 | 2,824,690,091.29 | 1,420,983,890.57 | 5,486,683,545.91 |
| 利息收入 | - | 0 | - | - |
| 已赚保费 | - | 0 | - | - |
| 手续费及佣金收入 | - | 0 | - | - |
| 二、营业总成本 | 4,005,418,466 | 2,625,439,993.61 | 1,306,494,171.94 | 5,115,071,415.63 |
| 营业成本 | 2,828,980,568.66 | 1,844,071,760.82 | 921,664,827.31 | 3,626,995,765.02 |
| 利息支出 | - | 0 | - | - |
| 手续费及佣金支出 | - | 0 | - | - |
| 退保金 | - | 0 | - | - |
| 赔付支出净额 | - | 0 | - | - |
| 提取保险合同准备金净额 | - | 0 | - | - |
| 保单红利支出 | - | 0 | - | - |
| 分保费用 | - | 0 | - | - |
| 税金及附加 | 24,561,215.22 | 15,869,812.88 | 7,590,567.66 | 24,886,213.44 |
| 销售费用 | 929,126,752.49 | 611,543,613.46 | 297,095,061.17 | 1,175,139,158.03 |
| 管理费用 | 178,329,990.03 | 121,936,075.31 | 63,139,325.09 | 231,402,054.54 |
| 研发费用 | 21,418,832.64 | 16,718,628.1 | 9,559,255.08 | 29,579,981.52 |
| 财务费用 | 23,001,106.96 | 15,300,103.04 | 7,445,135.63 | 27,068,243.08 |
| 其中:利息费用 | 11,830,853.99 | 8,588,927.65 | 4,171,084.01 | 15,058,755.36 |
| 其中:利息收入 | 5,287,924.72 | 4,110,344.25 | 1,768,551.06 | 10,031,238.21 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | 0 | 0 | - |
| 加:投资收益 | 1,864,691.3 | 1,698,404.31 | 547,530.14 | 5,026,267.16 |
| 净敞口套期收益 | 0 | 0 | 0 | - |
| 汇兑收益 | 0 | 0 | 0 | - |
| 资产处置收益 | 2,036,370.2 | 1,583,707.04 | 1,232,204.83 | 3,739,424.49 |
| 资产减值损失(新) | -6,779,307.93 | -6,144,260.24 | -5,375,809.71 | -79,737,162.11 |
| 信用减值损失(新) | -3,616,288.78 | -2,165,384.11 | -2,290,350.11 | -14,739,112.86 |
| 其他收益 | 10,498,329.04 | 7,743,745.7 | 3,169,025.84 | 14,281,370.73 |
| 四、营业利润 | 313,310,159.17 | 201,966,310.38 | 111,772,319.62 | 300,182,917.69 |
| 加:营业外收入 | 1,021,609.78 | 561,130.65 | 242,713.32 | 1,225,781.74 |
| 减:营业外支出 | 3,574,591.34 | 2,226,752.64 | 1,224,790.64 | 7,017,979.03 |
| 五、利润总额 | 310,757,177.61 | 200,300,688.39 | 110,790,242.3 | 294,390,720.4 |
| 减:所得税费用 | 78,134,083.41 | 51,895,901.72 | 24,706,381.85 | 80,524,088.13 |
| 六、净利润 | 232,623,094.2 | 148,404,786.67 | 86,083,860.45 | 213,866,632.27 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 232,623,094.2 | 148,404,786.67 | 86,083,860.45 | 213,866,632.27 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 215,541,516.62 | 135,908,900.86 | 79,343,522.28 | 191,352,661.67 |
| 少数股东损益 | 17,081,577.58 | 12,495,885.81 | 6,740,338.17 | 22,513,970.6 |
| 扣除非经常损益后的净利润 | 210,989,557.08 | 132,056,760.71 | 77,906,920.42 | 185,407,173.9 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.54 | 0.34 | 0.2 | 0.48 |
| (二)稀释每股收益 | 0.54 | 0.34 | 0.2 | 0.48 |
| 八、其他综合收益 | 0 | - | - | 1,400,217.49 |
| 归属于母公司股东的其他综合收益 | 0 | - | - | 1,400,217.49 |
| 九、综合收益总额 | 232,623,094.2 | 148,404,786.67 | 86,083,860.45 | 215,266,849.76 |
| 归属于母公司股东的综合收益总额 | 215,541,516.62 | 135,908,900.86 | 79,343,522.28 | 192,752,879.16 |
| 归属于少数股东的综合收益总额 | 17,081,577.58 | 12,495,885.81 | 6,740,338.17 | 22,513,970.6 |
| 公告日期 | 2026-10-27 | 2026-08-28 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |